(Q40639880)

22 September 2017

title

Perillyl alcohol as a radio-/chemosensitizer in malignant glioma (English)

1 reference

22 September 2017

Deepika Rajesh

1

1 reference

22 September 2017

Rachelle A Stenzel

series ordinal

2

1 reference

22 September 2017

Steven P Howard

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

12 June 2003

1 reference

Journal of Biological Chemistry

22 September 2017

published in

1 reference

22 September 2017

volume

278

1 reference

22 September 2017

issue

38

1 reference

22 September 2017

page(s)

35968-35978

1 reference

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Medical Research Council adjuvant trial in high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Radiotherapy for brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Chemoprevention of mammary carcinogenesis by hydroxylated derivatives of d-limonene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Antileukemia activity of perillyl alcohol (POH): uncoupling apoptosis from G0/G1 arrest suggests that the primary effect of POH on Bcr/Abl-transformed cells is to induce growth arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Modulation of small G protein isoprenylation by anticancer monoterpenes in in situ mammary gland epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Induction of AP-1 activity by perillyl alcohol in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

A phase II trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern Cooperative Oncology Group Study E2E96.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

21 January 2018

Fas ligand, death gene.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

How cells die: apoptosis pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

The role of Fas ligand in immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Fas-ligand: privilege and peril

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Ionizing radiation as a response-enhancing agent for CD95-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Fractionated gamma-irradiation renders tumour cells more responsive to apoptotic signals through CD95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Adenovirus-mediated overexpression of Fas induces apoptosis of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

T98G: An anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Characterization of metabotropic glutamate receptors in rat C6 glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Opposite effects of the overexpression of protein kinase C gamma and delta on the growth properties of human glioma cell line U251 MG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Transcriptional activation of TRADD mediates p53-independent radiation-induced apoptosis of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Differential modulation of apoptosis sensitivity in CD95 type I and type II cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Okadaic acid stimulates apoptosis through expression of Fas receptor and Fas ligand in human oral squamous carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Ceramide levels are inversely associated with malignant progression of human glial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

Molecular determinants of apoptosis induced by cytotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M303280200

21 January 2018

Identifiers

DOI

10.1074/JBC.M303280200

1 reference

22 September 2017

1 reference